New Study Explores Gender Outcome Disparities in Glioblastoma
February 25, 2019 | City of Hope
A nationwide team of researchers that includes City of Hope’s Translational Genomics Research Institute (TGen) has identified molecular differences that explain why men die of glioblastoma, a type of brain cancer, at nearly twice the rate of women.
Cell lines used for research don't reflect patient diversity, study shows
February 25, 2019 | Zen Vuong
City of Hope scientist, Rick Kittles, Ph.D., and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.
Enrolling: New CAR T Trial for Breast Cancer with Brain Metastasis
February 24, 2019 | Letisia Marquez
"For a woman who already has breast cancer, learning that a brain tumor has developed can be a frightening diagnosis because there are few treatment options available.
CAR T Trial for CNS Lymphoma Shows Promising Results
February 19, 2019 | Cara Martinez
Xiuli Wang, Ph.D., found that delivering one injection of CAR T cells — a powerful treatment that uses a patient’s own immune system to fight cancerous cells without harming neighboring healthy cells — directly into a specific compartment of the brain is more accurate and potent than existing therapies.
Ph.D. candidate leads groundbreaking study for neurodegenerative disease
October 17, 2018 | Maxine Nunes
Li Li's work, as a Ph.D. candidate at City of Hope, with Alexander disease may also shed new light on similar neurodegenerative conditions such as Parkinson’s, Alzheimer’s, and amyotrophic lateral sclerosis.
New therapy shows promise for melanoma metastasized to the brain
October 1, 2018 | Maxine Nunes
Oncologist Kim Margolin, M.D., brings new hope to people with melanoma that has metastasized to the brain with a remarkable new study.